MENU

Larimar Therapeutics (LRMR) Ownership - Who owns Larimar Therapeutics?

Profile

Industry
N/A
Address
Three Bala Plaza East
Phone
+1 844 511-9056
Employees
42
Web
https://www.larimartx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
601.33M
P/E Ratio
N/A
Total Cash
227.3M
Projected Growth
N/A
Total Debt
5.35M
Revenue
N/A
Risk (Beta)
1.03
Dividend Yield
N/A
Total Cash/Share
3.56
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

LRMR
Capitalization
601M
P/E Ratio
N/A
Risk (Beta)
1.03
Dividend Yield
N/A
Total Cash
227M
Total Cash/Share
3.56
Total Debt
5.35M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
231M
P/B Ratio
2.60
Cash Flow
N/A
Earnings
-0.96
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
64K
Current Ratio
17.99
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-50.54M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-24.56
Shares Held By Institutions
526M
Shares Outstanding - Current
63.8M
Total Liabilities
17.4M
Total Volume MTD
N/A
Value
N/A
Gain YTD
107.143
View a ticker or compare two or three
LRMR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a clinical-stage biopharmaceutical company, which engages in the research and development of a therapeutic treatment for mitochondrial disorders and Friedreich's ataxia

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Three Bala Plaza East
Phone
+1 844 511-9056
Employees
42
Web
https://www.larimartx.com